Vaccines Market
Market Insights on Vaccines covering sales outlook, demand forecast & up-to-date key trends
Vaccines Market by Technology, Type, Route of Administration, Disease Indication, End User & Region - Forecast 2022 - 2032
Vaccines Market Outlook (2022-2032)
[332 Pages Report] The global vaccines market size was valued at US$ 42 Bn in 2021 and is forecast to grow at a prolific CAGR of 10% during the forecast period between 2022 and 2032, reaching around US$ 120 Bn by 2032. Growth in the vaccines market is driven by rising prevalence of chronic and infectious diseases and increasing vaccines demand across developed and developing nations.
Market Outlook:
|
Data Points |
Market Insights |
|
Vaccines Market Value 2021 |
USD 42 Bn |
|
Vaccines Market Projected Value 2032 |
USD 120 Bn |
|
Vaccines Market Forecast CAGR (2022-2032) |
10.0% |
|
Key Players |
Merck & Co., Inc, GlaxoSmithKline, Pfizer BioNTech; Sanofi SA, CSL Limited, Emergent Biosolutions Inc., Johnson & Johnson (J&J), AstraZeneca plc, Bavarian Nordic A/S, and Mitsubishi Tanabe Pharma Corporation |
As the world is witnessing frequent outbreaks of diseases, governments and healthcare institutions are continuously looking for ways to tackle these diseases as well as to minimize the economic burden caused by these outbreaks. One such approach is the use of vaccines.
Vaccines have become highly sought-after healthcare products used for preventing and treating numerous diseases. These vaccines significantly enhance the immunity system of individuals and thus provide longer protection against diseases. They have significantly helped in controlling a number of diseases like polio and smallpox. Rising inclination towards vaccines for improving immunity against diseases is a major factor driving the growth of vaccines market.
Similarly, rising incidence of diseases worldwide is encouraging the adoption of vaccines, thereby creating prospects for the growth of vaccines market. Deadly diseases such as tuberculosis, cancer, influenza, and pneumonia have high fatality rates, which is compelling people to opt for vaccinations. For instance, as per the World Health Organization (WHO), around 1.5 million people died from tuberculosis in 2020 while over 10 million people fell ill with TB.
Additionally, increasing public awareness about benefits of vaccination along with rising government support in R&D is likely to act as a catalyst for the growth of vaccines market.
Let us know your requirement to get
100% FREE customization
2015-2021 Market Demand Outlook for Vaccines Market Compared to 2022-2032 Forecast
Global vaccines demand is anticipated to rise at 10% CAGR during the forecast period from 2022 and 2032. Factors such as rising prevalence of chronic and infectious diseases, increase in immunization programs, advancements in vaccine technology, and changing attitude towards vaccines are some of the major factors expected to drive the growth in vaccines market during the forecast period.
Since their invention, vaccines have completely revolutionized the healthcare industry across the world. They have become ideal healthcare preventive products used for enhancing immunity against numerous diseases. Expansion of prevention vaccines market and growing awareness among people of developing regions about the benefits of vaccines is likely to boost the vaccines market growth.
Furthermore, rising need for protecting children from deadly chronic and infectious diseases like tuberculosis, cancer, hepatitis, influence etc. will create lucrative opportunities for vaccine manufacturers during the forecast period. According to the United Nations Children’s Fund (UNICEF), each year vaccination saves 2 to 3 million children from deadly diseases.
Vaccine manufacturing giants like Pfizer and GSK are vigorously investing in vaccine research and development for introducing new products with highly effective nature. Besides this, they are holding various trials for establishing the safety and efficacy of vaccines. For instance, in January 2022, Pfizer Inc., and BioNTech SE initiated a clinical study to evaluate the safety, immunogenicity, and tolerability of an Omicron-based vaccine candidate in adults aged 18 to 55.
Rapidly evolving technology has a profound impact on the vaccines market trends. Developments like the introduction of genetic engineering and lab automation are helping vaccine manufacturers to develop low-cost vaccines, which will help the, to penetrate attractive market and eventually enable vaccines market access.
Additionally, various initiatives taken by governments of emerging nations for launching mass vaccinations drives will augment the overall vaccines industry worth in the future.
Which Factor are Challenging the Vaccine Market Growth?
"High Capital Investments and Low Purchasing Power in Emerging Markets May Impede Market Development."
Development of vaccines is a lengthy, complicated, and expensive process. As a result, most of the vaccines are usually costlier, which is acting as a major hurdle in the growth of vaccines market. Similarly, lack of awareness and poor healthcare infrastructure across developing regions have also hampered vaccines market access.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-Wise Insights
Why is the U.S. Considered a Prominent Market for Vaccines?
The U.S. was the largest market for vaccines in 2022 and is forecast to grow at a prolific CAGR over the forecast period, owing to the leavy presence of leading vaccine manufacturers, increasing investments in research and development, continuous vaccine launches and approvals, availability of highly advanced technologies, awareness among people about latest vaccines market trends, and expansion of veterinary vaccines market.
Similarly, rising incidence of infectious and chronic diseases in the country has become a crucial factor in boosting vaccines market growth. According to the Centers for Disease Control and Prevention (CDC), around 6,400,000 to 11,000,000 flu illnesses cases were recorded between October 1, 2021 through May 7, 2022 in the United States.
People in the United States are spending large amounts on vaccines to make themselves immune to various diseases. Thus, growing concerns about rising cases of various infectious diseases and positive attitude towards vaccines will significantly increase vaccine industry worth in the future.
Furthermore, increasing government initiatives coupled with expansion of COVID-19 vaccine market size is expected to boost the growth of vaccines market in the United States during the forthcoming period.
How Will the Vaccines Market Fare in China?
“Changing Attitudes Towards Vaccines and Favorable Government Support Creating Space for Vaccine Market Growth in China”
As per FMI, the vaccines market in China is poised to exhibit strong on the back of increasing government spending for immunization programs, changing attitude of people towards vaccinations, rise in development of novel vaccines, emergence of new vaccine market trends, surge in various diseases, and expansion of meningococcal vaccines market in the country.
Furthermore, rapidly growing population and rising health awareness among people in the country is making conducive environment for the growth of vaccines market.
Demand for vaccines was especially high during the COVID-19 pandemic and it is expected to continue at a steady pace during the post pandemic period as people's attitude towards vaccines takes a positive turn.
Category-Wise Insights
By Technology, Which Segment Leads the Global Vaccines market?
“Demand for Conjugate Vaccines to Remain High in the Vaccines Market”
As per FMI, the conjugate vaccines segment accounted for the largest share of the global vaccine market by technology type due to increased spending by government and private companies on its development. Rising preference for conjugate vaccines is due to their various additional features including greater antibody persistence and avidity.
Growing demand for conjugate vaccines due to their ability to provide long-lasting immunity against diseases will continue to offer lucrative opportunities to vaccine manufacturers during the forecast period, thereby boosting vaccines market growth.
Which Disease Indication Segment Leads the Vaccines Market?
“Pneumococcal Diseases Segment Creating Maximum Growth Opportunities for Vaccine Manufacturers”
Based on diseases indication, pneumococcal diseases segment accounts for the largest revenue share in the global vaccines market. This can be attributed to the rising prevalence of pneumococcal diseases, growing awareness among people about these diseases, expansion of pneumococcal vaccines market, and increasing government initiatives to encourage the adoption of vaccines for reducing the mortality rate of pneumococcal diseases, and
According to the World Health Organization (WHO), in 2017, pneumonia killed over 808 000 children under the age of 5. This rise in mortality rate worldwide is expected to encourage the adoption of vaccines during the forthcoming years, which in turn boost vaccines market growth.
Which is the leading End User Segment in the Vaccine Market?
“Expansion of Pediatric Vaccines Market Spurring Pediatric Vaccines Segment Growth”
Based on end user, pediatric vaccines segment accounts for a significant share of the global vaccine market in 2022 and this trend is likely to continue during the forecast period. This is attributed to the rising need for preventing children from a wide range of diseases, mandatory childhood vaccination policies, and rapid growth of pediatric vaccine market.
Similarly, increasing efforts of vaccine manufacturers to develop advanced vaccines with long term effectiveness for children will favor growth of this segment during the forecast period.
Which is the Most Preferred Route of Administration?
“Intramuscular & Subcutaneous Routes Remain the Most Preferred Route of Administration”
As per FMI, intramuscular and subcutaneous routes are the most preferred methods used by medical professionals globally. These routes are especially ideal when larger volumes drugs are to be administrated into the body.
Administration of drugs through intramuscular route offers various benefits which includes rapid absorption and less pain.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Competitive Landscape
Leading vaccine manufacturers in the global vaccines market include Merck & Co., Inc, GlaxoSmithKline, Pfizer BioNTech; Sanofi SA, CSL Limited, Emergent Biosolutions Inc., Johnson & Johnson (J&J), AstraZeneca plc, Bavarian Nordic A/S, and Mitsubishi Tanabe Pharma Corporation. Out of these GSK, Pfizer, Mark and Sanofi are the largest manufacturers of vaccines controlling around 90% of the vaccine supply by volume.
These leading players are continuously investing in research and development activities for introducing novel vaccines with long term efficacy. Besides this, they are adopting growth strategies such as new product launches and approvals, partnerships, acquisitions, and strengthening of distribution channels to expand their global footprint. For instance,
- In 2021, MSD Pharmaceuticals, a wholly-owned subsidiary of Merck Sharp & Dohme, launched “Gardasil 9”, India’s first gender neutral HPV vaccine.
- In April 2020, the U.S. Food and Drug Administration (FDA), approved Sanofi’s MenQuadfi vaccine for the prevention of invasive meningococcal diseases in persons aged 2 years and older.
- In 2021, Abbott launched a new inactivated quadrivalent vaccine for influenza in India that offers protection against four virus strains, in India.
Scope Of Report
FMI’s latest report presents an in-depth analysis of vaccines market by discussing about various growth shaping factors like drivers, restrains, prevailing trends, and emerging opportunities. It breaks down the market into various segments and sub-segments to make it more interesting for customers.
The report explains how rapid surge in chronic and infectious diseases is pushing the global vaccines market into the spotlight. Besides this, it provides answers to queries like how will increase in mass vaccination programs influence vaccines market growth? What is the impact of evolving COVID vaccine market on global vaccine sales? And what are the latest vaccine market trends?
FMI also provides insights into consumer demands and explains how global vaccine companies are innovating to meet those demands. Apart from examining the impact of government initiatives on vaccines sales, the report highlights the interrelationship between vaccines market and preventive vaccines market to explore hidden opportunities.
The global vaccines market report also covers growth strategies adopted by leading vaccine manufacturers to penetrate attractive markets.
The Vaccines market analysis includes:
- A 10-year realistic vaccine sales forecast slicing across multiple verticals
- Market dynamics including drivers, restraints, and emerging opportunities
- Information about current vaccine market trends
- Role of government initiatives and investments in the rapid expansion of vaccines market.
- Growth potential in developing economies
- Vaccine market segmentation and insights into leading segments along with their respective shares, growth forecast and market potential.
- Top vaccines manufacturers their strategies for developing new revenue streams
- The winning imperatives in vaccines market
- Pricing analysis
|
Attribute |
Details |
|
Forecast Period |
2022-2032 |
|
Historic Data Available for |
2015-2021 |
|
Market Analysis |
USD Million for Value |
|
Report Coverage |
Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives |
|
Key Segments Covered |
|
|
Key regions covered |
|
|
End User |
|
|
Key companies profiled |
Sanofi SA, Merck & Co., Inc, Pfizer BioNTech, CSL Limited, Johnson & Johnson (J&J), Emergent Biosolutions Inc., AstraZeneca plc, Bavarian Nordic A/S, and Mitsubishi Tanabe Pharma Corporation |
|
Customization & pricing |
Available upon request |
Vaccine Market Segmentation
By Technology:
- Conjugate Vaccines
- Inactivated and Subunit Vaccines
- Live attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Viral Vector Vaccines
By Type:
- Monovalent Vaccines
- Multivalent Vaccines
By Route of Administration:
- Intramuscular & Subcutaneous Administration
- Oral Administration
- Other routes (Intranasal, Intradermal and Percutaneous)
By Disease Indication:
- Influenza
- Pneumococcal Diseases
- Combination Vaccines
- HPV
- Herpes Zoster
- Meningococcal Diseases
- Rotavirus
- MMR
- Varicella
- Hepatitis
- DTP
- Polio
- Covid-19
- Other Disease Indications (Cancer, Dengue, Tuberculosis, Typhoid, Japanese Encephalitis, Rabies, Yellow Fever, and Allergies)
By End User:
- Pediatric Vaccines
- Adult Vaccines
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa (MEA)
Frequently Asked Questions
The global vaccine market was valued at US$ 42 Bn in 2021.
The vaccines market is expected to grow at a CAGR of 10% during the forecast period.
FMI predicts vaccines market to reach a valuation of US$ 120 Bn by 2032.
North America is expected to offer lucrative opportunities for the growth of vaccines market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. FMI Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Vaccines Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Vaccines Market By Country, US$ Mn
4.2. Vaccines Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Vaccines Market Growth
4.5.3. Vaccines Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Vaccines Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Vaccines Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Vaccines Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Technology
8.1. Introduction / Key Findings
8.2. Historical Market Value (US$ Mn) and Analysis By Technology, 2015-2021
8.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Technology, 2022-2032
8.3.1. Conjugate Vaccines
8.3.2. Inactivated & Subunit Vaccines
8.3.3. Live Attenuated Vaccines
8.3.4. Recombinant Vaccines
8.3.5. Toxoid Vaccines
8.3.6. Viral Vector Vaccines
8.4. Market Attractiveness Analysis By Technology
9. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Type
9.1. Introduction / Key Findings
9.2. Historical Market Value (US$ Mn) and Analysis By Type, 2015-2021
9.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Type, 2022-2032
9.3.1. Monovalent Vaccines
9.3.2. Multivalent Vaccines
9.4. Market Attractiveness Analysis By Type
10. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Route of Administration
10.1. Introduction / Key Findings
10.2. Historical Market Value (US$ Mn) and Analysis By Route of Administration, 2015-2021
10.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Route of Administration, 2022-2032
10.3.1. Intramuscular & Subcutaneous Administration
10.3.2. Oral Administration
10.3.3. Other Routes of Administration (Intranasal, Intradermal, and Percutaneous)
10.4. Market Attractiveness Analysis By Route of Administration
11. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Disease Indication
11.1. Introduction / Key Findings
11.2. Historical Market Value (US$ Mn) and Analysis By Disease Indication, 2015-2021
11.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Disease Indication, 2022-2032
11.3.1. Influenza
11.3.2. Pneumococcal Diseases
11.3.3. Combination Vaccines
11.3.4. HPV
11.3.5. Herpes Zoster
11.3.6. Meningococcal Diseases
11.3.7. Rotavirus
11.3.8. MMR
11.3.9. Varicella
11.3.10. Hepatitis
11.3.11. DTP
11.3.12. Polio
11.3.13. COVID 19
11.3.14. Other Disease Indications (Cancer, Dengue, Tuberculosis, Typhoid, Japanese Encephalitis, Rabies, Yellow Fever, and Allergies)
11.4. Market Attractiveness Analysis By Disease Indication
12. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By End-user
12.1. Introduction / Key Findings
12.2. Historical Market Value (US$ Mn) and Analysis By End-user, 2015-2021
12.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By End-user, 2022-2032
12.3.1. Pediatric Vaccines
12.3.2. Adult Vaccines
12.4. Market Attractiveness Analysis By End-user
13. Global Vaccines Market Analysis 2015-2021 and Forecast 2022-2032, By Region
13.1. Introduction
13.2. Historical Market Value (US$ Mn) and Analysis By Region, 2015-2021
13.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. Asia Pacific
13.3.5. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Vaccines Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.2. By Route of Administration
14.4.3. By Technology
14.4.4. By Type
14.4.5. By Disease Indication
14.4.6. By End-user
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Route of Administration
14.5.3. By Technology
14.5.4. By Type
14.5.5. By Disease Indication
14.5.6. By End-user
15. Latin America Vaccines Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Brazil
15.4.1.2. Mexico
15.4.1.3. Rest of Latin America
15.4.2. By Route of Administration
15.4.3. By Technology
15.4.4. By Type
15.4.5. By Disease Indication
15.4.6. By End-user
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Route of Administration
15.5.3. By Technology
15.5.4. By Type
15.5.5. By Disease Indication
15.5.6. By End-user
16. Europe Vaccines Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. France
16.4.1.3. U.K.
16.4.1.4. Italy
16.4.1.5. Russia
16.4.1.6. Rest of Europe
16.4.2. By Route of Administration
16.4.3. By Technology
16.4.4. By Type
16.4.5. By Disease Indication
16.4.6. By End-user
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Route of Administration
16.5.3. By Technology
16.5.4. By Type
16.5.5. By Disease Indication
16.5.6. By End-user
17. Asia Pacific Vaccines Market Analysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. China
17.4.1.2. Japan
17.4.1.3. South Korea
17.4.1.4. Rest of Asia Pacific
17.4.2. By Route of Administration
17.4.3. By Technology
17.4.4. By Type
17.4.5. By Disease Indication
17.4.6. By End-user
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Route of Administration
17.5.3. By Technology
17.5.4. By Type
17.5.5. By Disease Indication
17.5.6. By End-user
18. Middle East and Africa Vaccines Market Analysis 2015-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
18.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
18.4.1. By Country
18.4.1.1. GCC Countries
18.4.1.2. South Africa
18.4.1.3. Turkey
18.4.1.4. Rest of Middle East and Africa
18.4.2. By Route of Administration
18.4.3. By Technology
18.4.4. By Type
18.4.5. By Disease Indication
18.4.6. By End-user
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Route of Administration
18.5.3. By Technology
18.5.4. By Type
18.5.5. By Disease Indication
18.5.6. By End-user
19. Key Countries Vaccines Market Analysis 2015-2021 and Forecast 2022-2032
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. US Vaccines Market Analysis
19.2.1. Value Proportion Analysis by Market Taxonomy
19.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.2.2.1. By Route of Administration
19.2.2.2. By Technology
19.2.2.3. By Type
19.2.2.4. By Disease Indication
19.2.2.5. By End-user
19.3. Canada Vaccines Market Analysis
19.3.1. Value Proportion Analysis by Market Taxonomy
19.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.3.2.1. By Route of Administration
19.3.2.2. By Technology
19.3.2.3. By Type
19.3.2.4. By Disease Indication
19.3.2.5. By End-user
19.4. Mexico Vaccines Market Analysis
19.4.1. Value Proportion Analysis by Market Taxonomy
19.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.4.2.1. By Route of Administration
19.4.2.2. By Technology
19.4.2.3. By Type
19.4.2.4. By Disease Indication
19.4.2.5. By End-user
19.5. Brazil Vaccines Market Analysis
19.5.1. Value Proportion Analysis by Market Taxonomy
19.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.5.2.1. By Route of Administration
19.5.2.2. By Technology
19.5.2.3. By Type
19.5.2.4. By Disease Indication
19.5.2.5. By End-user
19.6. Germany Vaccines Market Analysis
19.6.1. Value Proportion Analysis by Market Taxonomy
19.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.6.2.1. By Route of Administration
19.6.2.2. By Technology
19.6.2.3. By Type
19.6.2.4. By Disease Indication
19.6.2.5. By End-user
19.7. France Vaccines Market Analysis
19.7.1. Value Proportion Analysis by Market Taxonomy
19.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.7.2.1. By Route of Administration
19.7.2.2. By Technology
19.7.2.3. By Type
19.7.2.4. By Disease Indication
19.7.2.5. By End-user
19.8. Italy Vaccines Market Analysis
19.8.1. Value Proportion Analysis by Market Taxonomy
19.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.8.2.1. By Route of Administration
19.8.2.2. By Technology
19.8.2.3. By Type
19.8.2.4. By Disease Indication
19.8.2.5. By End-user
19.9. Russia Vaccines Market Analysis
19.9.1. Value Proportion Analysis by Market Taxonomy
19.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.9.2.1. By Route of Administration
19.9.2.2. By Technology
19.9.2.3. By Type
19.9.2.4. By Disease Indication
19.9.2.5. By End-user
19.10. UK Vaccines Market Analysis
19.10.1. Value Proportion Analysis by Market Taxonomy
19.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.10.2.1. By Route of Administration
19.10.2.2. By Technology
19.10.2.3. By Type
19.10.2.4. By Disease Indication
19.10.2.5. By End-user
19.11. China Vaccines Market Analysis
19.11.1. Value Proportion Analysis by Market Taxonomy
19.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.11.2.1. By Route of Administration
19.11.2.2. By Technology
19.11.2.3. By Type
19.11.2.4. By Disease Indication
19.11.2.5. By End-user
19.12. Japan Vaccines Market Analysis
19.12.1. Value Proportion Analysis by Market Taxonomy
19.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.12.2.1. By Route of Administration
19.12.2.2. By Technology
19.12.2.3. By Type
19.12.2.4. By Disease Indication
19.12.2.5. By End-user
19.13. South Korea Vaccines Market Analysis
19.13.1. Value Proportion Analysis by Market Taxonomy
19.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.13.2.1. By Route of Administration
19.13.2.2. By Technology
19.13.2.3. By Type
19.13.2.4. By Disease Indication
19.13.2.5. By End-user
19.14. GCC Countries Vaccines Market Analysis
19.14.1. Value Proportion Analysis by Market Taxonomy
19.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.14.2.1. By Route of Administration
19.14.2.2. By Technology
19.14.2.3. By Type
19.14.2.4. By Disease Indication
19.14.2.5. By End-user
19.15. South Africa Vaccines Market Analysis
19.15.1. Value Proportion Analysis by Market Taxonomy
19.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.15.2.1. By Route of Administration
19.15.2.2. By Technology
19.15.2.3. By Type
19.15.2.4. By Disease Indication
19.15.2.5. By End-user
19.16. Turkey Vaccines Market Analysis
19.16.1. Value Proportion Analysis by Market Taxonomy
19.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.16.2.1. By Route of Administration
19.16.2.2. By Technology
19.16.2.3. By Type
19.16.2.4. By Disease Indication
19.16.2.5. By End-user
19.16.3. Competition Landscape and Player Concentration in the Country
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. By Regional footprint of Players
20.4.2. Product footprint by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. GlaxoSmithKline plc
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Sales Footprint
21.3.1.4. Strategy Overview
21.3.2. Merck & Co., Inc.
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Sales Footprint
21.3.2.4. Strategy Overview
21.3.3. Pfizer
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Sales Footprint
21.3.3.4. Strategy Overview
21.3.4. Sanofi SA
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Sales Footprint
21.3.4.4. Strategy Overview
21.3.5. CSL Limited
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Sales Footprint
21.3.5.4. Strategy Overview
21.3.6. Emergent BioSolutions Inc.
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Sales Footprint
21.3.6.4. Strategy Overview
21.3.7. Johnson & Johnson (J&J)
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Sales Footprint
21.3.7.4. Strategy Overview
21.3.8. AstraZeneca
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Sales Footprint
21.3.8.4. Strategy Overview
21.3.9. Bavarian Nordic A/S
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Sales Footprint
21.3.9.4. Strategy Overview
21.3.10. Mitsubishi Tanabe Pharma Corporation
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Sales Footprint
21.3.10.4. Strategy Overview
22. Assumptions and Acronyms Used
23. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021
Table 2: Global Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032
Table 3: Global Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021
Table 4: Global Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032
Table 5: Global Vaccines Market Value (US$ Mn), By Type, 2015 – 2021
Table 6: Global Vaccines Market Value (US$ Mn), By Type, 2022 – 2032
Table 7: Global Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021
Table 8: Global Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032
Table 9: Global Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021
Table 10: Global Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032
Table 11: Global Vaccines Market, By Region, 2015 – 2021
Table 12: Global Vaccines Market, By Region, 2022 – 2032
Table 13: North America Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021
Table 14: North America Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032
Table 15: North America Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021
Table 16: North America Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032
Table 17: North America Vaccines Market Value (US$ Mn), By Type, 2015 – 2021
Table 18: North America Vaccines Market Value (US$ Mn), By Type, 2022 – 2032
Table 19: North America Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021
Table 20: North America Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032
Table 21: North America Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021
Table 22: North America Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032
Table 23: North America Vaccines Market, By Country, 2015 – 2021
Table 24: North America Vaccines Market, By Country, 2022 – 2032
Table 25: Latin America Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021
Table 26: Latin America Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032
Table 27: Latin America Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021
Table 28: Latin America Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032
Table 29: Latin America Vaccines Market Value (US$ Mn), By Type, 2015 – 2021
Table 30: Latin America Vaccines Market Value (US$ Mn), By Type, 2022 – 2032
Table 31: Latin America Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021
Table 32: Latin America Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032
Table 33: Latin America Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021
Table 34: Latin America Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032
Table 35: Latin America Vaccines Market, By Country, 2015 – 2021
Table 36: Latin America Vaccines Market, By Country, 2022 – 2032
Table 37: Europe Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021
Table 38: Europe Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032
Table 39: Europe Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021
Table 40: Europe Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032
Table 41: Europe Vaccines Market Value (US$ Mn), By Type, 2015 – 2021
Table 42: Europe Vaccines Market Value (US$ Mn), By Type, 2022 – 2032
Table 43: Europe Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021
Table 44: Europe Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032
Table 45: Europe Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021
Table 46: Europe Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032
Table 47: Europe Vaccines Market, By Country, 2015 – 2021
Table 48: Europe Vaccines Market, By Country, 2022 – 2032
Table 49: Asia Pacific Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021
Table 50: Asia Pacific Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032
Table 51: Asia Pacific Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021
Table 52: Asia Pacific Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032
Table 53: Asia Pacific Vaccines Market Value (US$ Mn), By Type, 2015 – 2021
Table 54: Asia Pacific Vaccines Market Value (US$ Mn), By Type, 2022 – 2032
Table 55: Asia Pacific Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021
Table 56: Asia Pacific Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032
Table 57: Asia Pacific Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021
Table 58: Asia Pacific Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032
Table 59: Asia Pacific Vaccines Market, By Country, 2015 – 2021
Table 60: Asia Pacific Vaccines Market, By Country, 2022 – 2032
Table 61: MEA Vaccines Market Value (US$ Mn), By Route of Administration, 2015 – 2021
Table 62: MEA Vaccines Market Value (US$ Mn), By Route of Administration, 2022 – 2032
Table 63: MEA Vaccines Market Value (US$ Mn), By Technology, 2015 – 2021
Table 64: MEA Vaccines Market Value (US$ Mn), By Technology, 2022 – 2032
Table 65: MEA Vaccines Market Value (US$ Mn), By Type, 2015 – 2021
Table 66: MEA Vaccines Market Value (US$ Mn), By Type, 2022 – 2032
Table 67: MEA Vaccines Market Value (US$ Mn), By End-user, 2015 – 2021
Table 68: MEA Vaccines Market Value (US$ Mn), By End-user, 2022 – 2032
Table 69: MEA Vaccines Market Value (US$ Mn), By Disease Indication, 2015 – 2021
Table 70: MEA Vaccines Market Value (US$ Mn), By Disease Indication, 2022 – 2032
Table 71: MEA Vaccines Market, By Country, 2015 – 2021
Table 72: MEA Vaccines Market, By Country, 2022 – 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 2: Global Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Vaccines Market Share, By Route of Administration, 2022 & 2032
Figure 4: Global Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032
Figure 5: Global Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032
Figure 6: Global Vaccines Market Share, By Technology, 2022 & 2032
Figure 7: Global Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 8: Global Vaccines Market Attractiveness Index, By Technology – 2022-2032
Figure 9: Global Vaccines Market Share, By End-user, 2022 & 2032
Figure 10: Global Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 11: Global Vaccines Market Attractiveness Index, By End-user – 2022-2032
Figure 12: Global Vaccines Market Share, By Type, 2022 & 2032
Figure 13: Global Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 14: Global Vaccines Market Attractiveness Index, By Type – 2022-2032
Figure 15: Global Vaccines Market Share, By Disease Indication, 2022 & 2032
Figure 16: Global Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032
Figure 17: Global Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032
Figure 18: Global Vaccines Market Share, By Region, 2022 & 2032
Figure 19: Global Vaccines Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 20: Global Vaccines Market Attractiveness Index, By Region – 2022-2032
Figure 21: North America Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 22: North America Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 23: North America Vaccines Market Share, By Route of Administration, 2022 & 2032
Figure 24: North America Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032
Figure 25: North America Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032
Figure 26: North America Vaccines Market Share, By Technology, 2022 & 2032
Figure 27: North America Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 28: North America Vaccines Market Attractiveness Index, By Technology – 2022-2032
Figure 29: North America Vaccines Market Share, By End-user, 2022 & 2032
Figure 30: North America Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 31: North America Vaccines Market Attractiveness Index, By End-user – 2022-2032
Figure 32: North America Vaccines Market Share, By Type, 2022 & 2032
Figure 33: North America Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 34: North America Vaccines Market Attractiveness Index, By Type – 2022-2032
Figure 35: North America Vaccines Market Share, By Disease Indication, 2022 & 2032
Figure 36: North America Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032
Figure 37: North America Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032
Figure 38: North America Vaccines Market Share, By Country, 2022 & 2032
Figure 39: North America Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 40: North America Vaccines Market Attractiveness Index, By Country – 2022-2032
Figure 41: Latin America Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 42: Latin America Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 43: Latin America Vaccines Market Share, By Route of Administration, 2022 & 2032
Figure 44: Latin America Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032
Figure 45: Latin America Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032
Figure 46: Latin America Vaccines Market Share, By Technology, 2022 & 2032
Figure 47: Latin America Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 48: Latin America Vaccines Market Attractiveness Index, By Technology – 2022-2032
Figure 49: Latin America Vaccines Market Share, By End-user, 2022 & 2032
Figure 50: Latin America Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 51: Latin America Vaccines Market Attractiveness Index, By End-user – 2022-2032
Figure 52: Latin America Vaccines Market Share, By Type, 2022 & 2032
Figure 53: Latin America Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 54: Latin America Vaccines Market Attractiveness Index, By Type – 2022-2032
Figure 55: Latin America Vaccines Market Share, By Disease Indication, 2022 & 2032
Figure 56: Latin America Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032
Figure 57: Latin America Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032
Figure 58: Latin America Vaccines Market Share, By Country, 2022 & 2032
Figure 59: Latin America Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 60: Latin America Vaccines Market Attractiveness Index, By Country – 2022-2032
Figure 61: Europe Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 62: Europe Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 63: Europe Vaccines Market Share, By Route of Administration, 2022 & 2032
Figure 64: Europe Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032
Figure 65: Europe Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032
Figure 66: Europe Vaccines Market Share, By Technology, 2022 & 2032
Figure 67: Europe Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 68: Europe Vaccines Market Attractiveness Index, By Technology – 2022-2032
Figure 69: Europe Vaccines Market Share, By End-user, 2022 & 2032
Figure 70: Europe Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 71: Europe Vaccines Market Attractiveness Index, By End-user – 2022-2032
Figure 72: Europe Vaccines Market Share, By Type, 2022 & 2032
Figure 73: Europe Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 74: Europe Vaccines Market Attractiveness Index, By Type – 2022-2032
Figure 75: Europe Vaccines Market Share, By Disease Indication, 2022 & 2032
Figure 76: Europe Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032
Figure 77: Europe Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032
Figure 78: Europe Vaccines Market Share, By Country, 2022 & 2032
Figure 79: Europe Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 80: Europe Vaccines Market Attractiveness Index, By Country – 2022-2032
Figure 81: Asia Pacific Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 82: Asia Pacific Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 83: Asia Pacific Vaccines Market Share, By Route of Administration, 2022 & 2032
Figure 84: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032
Figure 85: Asia Pacific Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032
Figure 86: Asia Pacific Vaccines Market Share, By Technology, 2022 & 2032
Figure 87: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 88: Asia Pacific Vaccines Market Attractiveness Index, By Technology – 2022-2032
Figure 89: Asia Pacific Vaccines Market Share, By End-user, 2022 & 2032
Figure 90: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 91: Asia Pacific Vaccines Market Attractiveness Index, By End-user – 2022-2032
Figure 92: Asia Pacific Vaccines Market Share, By Type, 2022 & 2032
Figure 93: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 94: Asia Pacific Vaccines Market Attractiveness Index, By Type – 2022-2032
Figure 95: Asia Pacific Vaccines Market Share, By Disease Indication, 2022 & 2032
Figure 96: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032
Figure 97: Asia Pacific Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032
Figure 98: Asia Pacific Vaccines Market Share, By Country, 2022 & 2032
Figure 99: Asia Pacific Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 100: Asia Pacific Vaccines Market Attractiveness Index, By Country – 2022-2032
Figure 101: MEA Vaccines Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 102: MEA Vaccines Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 103: MEA Vaccines Market Share, By Route of Administration, 2022 & 2032
Figure 104: MEA Vaccines Market Y-o-Y Growth Projections, By Route of Administration – 2022-2032
Figure 105: MEA Vaccines Market Attractiveness Index, By Route of Administration – 2022-2032
Figure 106: MEA Vaccines Market Share, By Technology, 2022 & 2032
Figure 107: MEA Vaccines Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 108: MEA Vaccines Market Attractiveness Index, By Technology – 2022-2032
Figure 109: MEA Vaccines Market Share, By End-user, 2022 & 2032
Figure 110: MEA Vaccines Market Y-o-Y Growth Projections, By End-user – 2022-2032
Figure 111: MEA Vaccines Market Attractiveness Index, By End-user – 2022-2032
Figure 112: MEA Vaccines Market Share, By Type, 2022 & 2032
Figure 113: MEA Vaccines Market Y-o-Y Growth Projections, By Type – 2022-2032
Figure 114: MEA Vaccines Market Attractiveness Index, By Type – 2022-2032
Figure 115: MEA Vaccines Market Share, By Disease Indication, 2022 & 2032
Figure 116: MEA Vaccines Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032
Figure 117: MEA Vaccines Market Attractiveness Index, By Disease Indication – 2022-2032
Figure 118: MEA Vaccines Market Share, By Country, 2022 & 2032
Figure 119: MEA Vaccines Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 120: MEA Vaccines Market Attractiveness Index, By Country – 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
